Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 9;23(1):1442.
doi: 10.4102/sajhivmed.v23i1.1442. eCollection 2022.

Incidence of hepatitis C virus infection among people living with HIV: An Egyptian cohort study

Affiliations

Incidence of hepatitis C virus infection among people living with HIV: An Egyptian cohort study

Fatma Elrashdy et al. South Afr J HIV Med. .

Abstract

Background: Egypt used to have one of the highest hepatitis C virus (HCV) infection prevalence rates worldwide, with an estimated HCV prevalence of around 4.5% to 6.7%.

Objectives: To determine the HCV infection incidence rate amid Egyptian patients living with HIV.

Method: A total of 460 HIV-positive patients were recruited in a retrospective cohort study from Imbaba Fever Hospital, Cairo, between January 2016 and March 2019. The patients had a negative baseline and at least one other HCV antibody test. Hepatitis C virus antibody testing was done by antibody sandwich third-generation enzyme-linked immunosorbent assay. The hepatitis C virus infection incidence rate among HIV-infected patients was calculated using the person-time incidence rate.

Results: Two hundred and eighteen patients were finally included: 146 (31.7%) patients were excluded for having a positive baseline HCV Ab result and 96 patients were excluded for not having a follow-up HCV Ab test. Eighteen patients had HCV seroconversion (8.3%), achieving an incidence rate of 4.06 cases per 100 person-years (95% confidence interval: 3.87-4.24). Injection drug use (IDU) was the commonest risk factor among seroconverters, with an HCV incidence rate of 7.08 cases per 100 person-years. Injection drug use history was reported in 83.3% of the seroconverters and in only 47.2% of non-seroconverters; P = 0.005.

Conclusion: Egyptian HIV-infected patients show a high incidence rate of HCV infection especially among those who have a history of IDU. Accordingly, attention should be paid for prevention, screening and timely treatment of HCV in patients infected with HIV.

What this study adds: The demonstration of a high HCV infection incidence rate among HIV-infected patients and shows the need for screening and prevention in this population.

Keywords: Egypt; HCV screening; HCV seroconversion; IDU; incidence rate of HCV; people living with HIV.

PubMed Disclaimer

Conflict of interest statement

G.E. is a speaker, advisory board member and investigator for Gilead Science. All other authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

Figures

FIGURE 1
FIGURE 1
A flowchart illustrating the study population selection. Grey boxes denote the patients excluded from the study.

Similar articles

Cited by

References

    1. Platt L, Easterbrook P, Gower E, et al. . Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):797–808. 10.1016/S1473-3099(15)00485-5 - DOI - PubMed
    1. World Health Organization . Hepatitis C: Fact sheet [homepage on the Internet]. [updated 2021 Jul; cited 2022 Mar 18]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-c
    1. UNAIDS . Global HIV & AIDS statistics – 2021 fact sheet [homepage on the Internet]. [cited 2022 Mar 18]. Available from: www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
    1. El-Zanaty and Associates . Egypt health issues survey 2015. Rockville, MD: Ministry of Health and Population, ICF International; 2015.
    1. Waked I, Esmat G, Elsharkawy A, et al. . Screening and treatment program to eliminate hepatitis C in Egypt. N Engl J Med. 2020;382(12):1166–1174. 10.1056/NEJMsr1912628 - DOI - PubMed

LinkOut - more resources